1,1,3,3,3-pentafluoro-2-(fluoromethoxy)-1-propene,
Compound A (fluoroether),
FDTVE,
FDVE-2,2,
fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether,
pentafluoroisopropenyl fluoromethyl ether,
58109-34-5,
Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether,
Fluoromethyl pentafluoroprop-1-en-2-yl ether,
VMCHRPIQINOPJR-UHFFFAOYSA-N,
2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene,
FDTVE,
1-Propene, 1,1,3,3,3-pentafluoro-2-(fluoromethoxy)-,
1-Propene, 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-,
FDVE-2,2,
pentafluoroisopropenyl fluoromethyl ether,
AC1L2XVZ,
AC1Q4HFJ,
1,1,3,3,3-pentafluoro-2-(fluoromethoxy)-1-propene,
1,1,3,3,3-pentafluoro-2-(fluoromethoxy)prop-1-ene,
SCHEMBL2537811,
LS-123478,
fluoromethyl 1,1,1,3,3-pentafluoro-2-propenyl ether,
fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether,
SEVOFLURANE RELATED COMPOUND A (0.2 ML) (1,1,3,3,3-PENTAFLUOROISOPROPENYL FLUOROMETHYL ETHER),
COMPOUND A,
Sevoflurane Related Compo,
Compound A (fluoroether),
C4H2F6O,
SEVOFLURANERELATEDCOMPOUNDA,
C4-H2-F6-O,
AR-1J0858,
CID105015,
C078742,
59824-35-0,